Skip to main content

Published locations for SPIRIT-H2H results confirm superiority of ixekizumab over adalimumab for PsA

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. SPIRIT-H2H results confirm superiority of ixekizumab over adalimumab for PsA

User login

  • Reset your password
  • /content/spirit-h2h-results-confirm-superiority-ixekizumab-over-adalimumab-psa
  • /edermatologynews/article/212887/psoriatic-arthritis/spirit-h2h-results-confirm-superiority
  • /rheumatologynews/article/212887/psoriatic-arthritis/spirit-h2h-results-confirm-superiority
  • /rheumatology/article/212887/psoriatic-arthritis/spirit-h2h-results-confirm-superiority-ixekizumab
  • /dermatology/article/212887/psoriatic-arthritis/spirit-h2h-results-confirm-superiority-ixekizumab
  • /rheumatology/psoriatic-arthritis-resource-center/article/212887/psoriatic-arthritis/spirit-h2h
  • /psoriatic-arthritis-icymi/article/212887/psoriatic-arthritis/spirit-h2h-results-confirm-superiority